Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(13%)
Results Posted
20%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph early_phase_1
4
50%
Ph phase_2
2
25%
Ph not_applicable
2
25%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
4(50.0%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 14 (50.0%)
Phase 22 (25.0%)
N/A2 (25.0%)

Trials by Status

recruiting113%
terminated113%
withdrawn113%
completed563%

Recent Activity

1 active trials
Showing 5 of 8
recruitingnot_applicable

Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

NCT01269190
terminatedearly_phase_1

Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

NCT02714439
completednot_applicable

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

NCT02206048
completedphase_2

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

NCT05396781
completedearly_phase_1

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

NCT02420665
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01269190Not Applicable

Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

Recruiting
NCT02714439Early Phase 1

Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

Terminated
NCT02206048Not Applicable

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

Completed
NCT05396781Phase 2

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

Completed
NCT02420665Early Phase 1

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

Completed
NCT01384708Early Phase 1

Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer

Completed
NCT01384864Early Phase 1

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Completed
NCT02095847Phase 2

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8